Addiction to psychostimulants is a major public health problem with no available treatment.
INTRODUCTION
Cocaine and methamphetamine (MAP) are highly addictive and commonly abused psychostimulant substances and their use is a public health concern. There are currently no specific therapeutic agents with established efficacy for the treatment of either MAP or cocaine addiction. There is substantial evidence supporting a key role of the adenosine A2A receptors (A2AR) in regulating the behavioral properties of drugs of abuse (Brown and Short, 2008) .
However, its role in modulating the behavioral and neurochemical effects of psychostimulant substances remains largely unclear, mainly due to the discrepancies between outcomes from studies using pharmacological manipulation of A2AR in rodents compared with studies using the A2AR knockout (KO) mouse model. For instance, pharmacological activation of A2AR attenuates cocaine self-administration (Knapp et al., 2001 ) and decreases both cocaine and MAP locomotor sensitization (Filip et al., 2006; Shimazoe et al., 2000) . In contrast, global deletion of the A2AR gene has been shown to attenuate psychostimulant-induced hyperlocomotion and motor sensitization (Chen et al., 2000) . Evidence supports both facilitatory as well as antagonistic roles of striatal postsynaptic and presynaptic A2AR, respectively, in modulating psychostimulant-mediated responses (Shen et al., 2008) .
Expression of A2AR in the brain is highly enriched in the striatum (Rosin et al., 1998) , where pre-and post-synaptic receptors are known to play differential role in the modulation of behavioral responses to psychostimulants (Golembiowska and Zylewska, 1997; Quarta et al., 2004; Rodrigues et al., 2005; Shen et al., 2008) . A2AR post-synaptically co-localize with D2R in striatopallidal GABAergic neurons (Canals et al., 2003; Fink et al., 1992; Hillion et al., 2002) and functional antagonistic A2AR-D2R interactions have been demonstrated to negatively modulate the locomotor and rewarding effects of psychostimulant drugs (Ferre et al., 1997; Filip et al., 2006; Poleszak and Malec, 2002) . A2AR are also located pre-synaptically on cortical glutamatergic afferents projecting to the striatum (Ciruela et al., 2006; Popoli et al., 1995; Schiffmann et al., 2007) . In contrast to the antagonistic A2AR-D2R interaction, activation of presynaptic A2AR positively modulates the behavioral responses of psychostimulants by facilitating accumbal DA and glutamate release (Golembiowska and Zylewska, 1997; Quarta et al., 2004; Rodrigues et al., 2005) . Studies carried out in forebrain-specific and striatal-specific A2AR KO mice indicated a dominant role of the facilitatory effect of pre-synaptic extra-striatal A2AR over the antagonistic effects of post-synaptic striatal A2AR on modulating the behavioral effects of cocaine and phencyclidine (Shen et al., 2008) .
There is increasing evidence suggesting that A2AR are also co-localized and functionally interact with the mGlu5R . In particular, mGlu5R are expressed post-synaptically in striatopallidal GABAergic neurons, where they are co-expressed and functionally interact with A2AR to synergistically overcome D2R-mediated effects, both at the behavioral and molecular level (Coccurello et al., 2004; Ferre et al., 2002; Kachroo et al., 2005; Popoli et al., 2001 ).
Moreover, supra-additive effects of co-administration of sub-threshold doses of mGlu5R and A2AR antagonists have been reported in the facilitation of glutamate release to the striatum, suggesting presynaptic A2AR-Glu5R interactions to also regulate glutamatergic striatal neurotransmission (Rodrigues et al., 2005) . These receptor interactions have been shown to modulate motor deficits in an animal model of Parkinson's disease (Kachroo et al., 2005; Popoli et al., 2001) and to also regulate alcohol-seeking (Adams et al., 2008) and cocaine conditioning, behavior but not cocaine-induced hyperactivity (Brown et al., 2012) . However, the role of A2AR-mGlu5R interactions on addictive-related behavioral effects of MAP is currently unknown.
The aim of the present study was to characterize the role of A2AR and its interaction with mGlu5R on the behavioral and neurochemical effects associated with MAP and cocaine use. Therefore, we firstly investigated the effect of genetic and pharmacological antagonism of A2AR on the motor-activating effects of chronic MAP and cocaine. To assess the role of A2AR-mGlu5R interactions in regulating the motor and rewarding effects of MAP, we tested the effect of the combination of subthreshold doses of A2AR and mGlu5R antagonists on MAP-induced hyperactivity, stereotypic rearing and conditioned-place preference behavior of mice. The effect of A2AR and mGlu5R antagonists on MAP-induced hyperactivity was compared to the respective behavioral effects of cocaine. We further biochemically explored the presence of A2AR-mGlu5R interactions by assessing the effect of A2AR deletion on striatal mGlu5R binding in treatmentnaïve mice and following chronic MAP or cocaine administration in wild type (WT) and A2AR KO mice. Finally, given the evidence supporting a possible functional D2R-A2AR-mGlu5R trimeric receptor interaction in the striatum (Cabello et al., 2009), we also investigated the effect of A2AR deletion on striatal D2R binding, in treatment-naïve mice and following chronic MAP and cocaine administration.
MATERIALS AND METHODS

Animals
The methodology for the generation of A2AR KO mice (CD-1 background) used in the current study has been previously described (Ledent et al., 1997) . Male, 8-12 week-old, WT and A2AR KO, were housed individually in a controlled environment (12:12 hour light/dark cycle -lights on 06:00). Food and water were available ad libitum. All procedures received a favorable opinion from the University of Surrey Animal Welfare and Ethical Review Body and were approved by the UK Home Office under The Animals (Scientific Procedures) Act 1986. For genotyping, tail DNA was extracted using the DNeasy tissue kit, according to the manufacturer's instructions (QIAGEN, Germany). Genotyping was performed as previously described (Ledent et al., 1997) .
Confirmation of genotype
To confirm the genotype of the animals used in our studies, brain sections from all experimental WT and A2AR KO mice were processed for A2AR binding, using 10 nM [ 3 H]CGS21680
(PerkinElmer, USA) according to Bailey et al. (2002) . A2AR were only detected in striatal regions of WT mice and absent in A2AR KO mice (Supplementary Figure S1 ).
Chronic psychostimulant administration paradigms
A group of WT and A2AR KO mice (n = 7-11/group) were treated with a chronic steady-dose 'binge' cocaine administration paradigm as described by Metaxas et al. (2012) , consisting of 3 injections per day (at 11:00, 12:00 and 13:00) of either cocaine (15 mg/kg/injection, s.c., SigmaAldrich, UK) or saline (10 ml/kg/day, s.c.), for 14 days. Another cohort of WT and A2AR KO mice (n= 6/group) were administered with chronic steady-dose of MAP (1 mg/kg/day, i.p.;
Sigma-Aldrich, Dorset, UK) or saline (10 ml/kg/day, i.p.) for 10 days, according to Zanos et al. (2014b) .
Ambulatory and stereotypic rearing activity
Ambulatory activity was measured in locomotor chambers (40 cm length x 20 cm width x 20 cm height; Linton Instrumentation, Norfolk, UK). Each cage has two sets of 16 photocells, 2.5 cm apart, located 1 cm or 6 cm (referred to here as "vertical beams") above the cage floor.
Ambulatory time was defined by the total active time, and vertical activity (i.e., rearing) was defined by vertical beam-breaks, recorded every 5 min. Each daily session began with placing the mice in the locomotor chambers for 1 hour prior to drug administration, for assessing basal activity. Subsequently, locomotor activity was measured for either 60 min following each of the 3 daily cocaine/saline injections (total time: 3 hours) or for 3 hours following MAP/saline injection. Since there were no differences between the three daily cocaine injections in either WT or A2AR knockout mice (data not shown), total three-hour daily aggregated locomotor responses of cocaine-treated animals are reported. Effects of pharmacological co-antagonism of A2AR and mGlu5R on methamphetamineinduced conditioned place preference Male, 9-week old, WT mice were used for the conditioned place preference (CPP) studies. We used a CPP apparatus (Opto-Max Activity Meter v2.16, Columbus Instruments, OH, USA), as previously described by Zanos et al. (2014a) and Bailey et al. (2010) . Briefly, the MAP-induced CPP protocol consisted of a habituation phase, a pre-conditioning test, six conditioning sessions and a post-conditioning test ( Figure 3A ). On day 1 (i.e., habituation) and day 2 (i.e., preconditioning), WT mice were placed in the CPP apparatus and were allowed to explore both compartments for 20 min. During the conditioning phase, mice were administered with MAP 1 mg/kg, i.p. and placed in their least preferred compartment on alternating days (i.e., days 3, 5 and 7) and saline (10 ml/kg, i.p.) in their preferred compartment on days 4, 6 and 8 ( Figure 3A 
Effects
Effects of A2AR deletion on mGlu5R, D2R and DAT binding in treatment-naïve animals or following chronic cocaine and MAP administration
Since cocaine, but not MAP, acts primarily via blocking dopamine transporters (DAT) to exert its acute rewarding effects, DAT binding was also assessed in brains of naïve WT and A2AR KO mice to assess baseline differences. Quantitative autoradiography of mGlu5R, D2R and DAT procedures were performed as detailed previously (Bailey et al., 2008; Bailey et al., 2007; Georgiou et al., 2014) 
RESULTS
Basal ambulatory time and vertical locomotor activity of WT and A2AR KO mice
To investigate whether there are any baseline locomotor alterations induced by the genetic deletion of A2AR, basal (i.e., treatment-naïve) locomotor activity of WT and A2AR KO mice, defined as the total ambulatory time or vertical beam-breaks for 1 hour prior to any treatment injection on Day 1 of the chronic cocaine and MAP administration paradigms. There was no difference in either the ambulatory time or vertical activity between WT and A2AR KO mice (Supplementary Figure S2) .
Genetic deletion of A2AR modulates methamphetamine-but not cocaine-induced ambulatory and stereotypic rearing activity
Chronic treatment with either cocaine or MAP increased ambulatory time of WT as well as A2AR
KO mice compared to the control saline group (Figure 1A , C; Table 1 ). While no significant genotype effect on ambulatory time was observed following cocaine treatment ( Figure 1A ), MAP-induced increase of ambulatory time was significantly attenuated in the A2AR KO compared to WT mice (genotype effect: F (1, 20) = 7.78, p<0.05; Figure 1C ; Table 1) Cocaine administration caused a significant increase in vertical (stereotypic) activity ( Figure 1B ; Table 1 ); no significant effect of genotype on cocaine-induced vertical activity was observed. In contrast, MAP-induced increase of vertical activity was abolished in the A2AR KO ( Figure 1D ; Table 1 ). Vertical activity in MAP-treated A2AR KO mice did not differ from that of salinetreated A2AR KO mice.
A2AR-mGlu5R receptor interaction modulates methamphetamine-induced hyperactivity and stereotypic rearing behavior
In order to assess the role of A2AR-mGlu5R interaction in the modulation of MAP-induced hyperactivity and stereotypic rearing behavior, WT mice were treated with a combination of sub- (Figure 2 ).
A2AR-mGlu5R interaction mediates methamphetamine-induced conditioned place preference
We further investigated the role of A2AR-mGlu5R receptor interaction in the reinforcing properties of MAP by using a CPP paradigm ( Figure 3A ). Sub-threshold doses of SCH 58261
and MTEP were administered separately or in combination 30 min prior to post-conditioning test Table 2 ).
Chronic methamphetamine treatment did not alter D2R in wild-type or A2AR KO mice
Chronic MAP treatment did not induce any changes in the dopamine D2R binding (Supplementary Figure S5C , D) in WT or A2AR KO mice, and no genotype effect was observed (Table 1) .
Decreased mGlu5R binding in the striatum of treatment-naïve A2AR KO mice
We investigated the effects of global A2AR deletion on D2R, DAT and mGlu5R in the brain ( Figure 5 ). Quantitative autoradiographic binding of the striatal D2R and DAT showed no significant genotype effect or 'genotype' x 'brain region' interaction ( Figure 5 , Table 1 ).
However, compared to WT mice, mGlu5R binding was significantly lower in the nucleus accumbens core of A2AR KO mice, but not in the other brain regions analyzed (Figure 5C , F;
Supplementary Table 3) .
DISCUSSION
This is the first study to demonstrate the critical role of A2AR via its striatal interaction with mGlu5R in mediating the ambulatory, stereotypic rearing behavior and rewarding properties of MAP. Interestingly, and in contrast with MAP, neither A2AR nor the A2AR-mGlu5R interaction modulates the motor enhancing properties of cocaine in mice. These findings demonstrate a differential role of the A2AR and the A2AR-mGlu5R interactions in modulating the effects of two mechanistically distinct psychostimulants. In addition, we showed that A2AR deletion does not only alter striatal mGlu5R binding under physiological conditions, but also prevents the MAPinduced upregulation of striatal mGlu5R binding, thus further supporting the evidence for a functional striatal A2AR-mGlu5R interaction.
We show that both pharmacological antagonism and genetic deletion of A2AR attenuate MAPinduced stimulation of ambulatory activity. In addition, the present study is the first to demonstrate complete abolition of MAP-induced stereotypic rearing behavior in A2AR KO mice, To further investigate whether the effects of A2AR antagonism involves its interaction with mGlu5R, we investigated the effect of co-administration of sub-threshold doses of A2AR and mGlu5R antagonists on the ambulatory and stereotypic rearing behaviors induced by MAP. In line with the findings from the genetic deletion of A2AR, we also showed that sub-threshold coantagonism of A2AR and mGlu5R reduced ambulatory time and completely prevented MAPinduced rearing activity. Overall, these data clearly suggest a functional A2AR-mGlu5R interaction in the positive modulation of the motor enhancing properties of MAP. These findings are in agreement with studies showing synergistic interactions between A2AR and mGlu5R in the drug-seeking effect of alcohol and cocaine (Adams et al., 2008; Brown et al., 2012) , as well as, as well as in the manifestation of motor responses associated with Parkinson's disease Kachroo et al., 2005) . Specifically, combination of sub-threshold doses of A2AR and mGlu5R antagonists improved motor deficits in bilaterally 6-hydroxy-dopamine-lesioned rats (Coccurello et al, 2004) as well as in DA-depleted mice (Kachroo et al, 2005) , and prevented the conditioned cue-induced reinstatement of alcohol-seeking (Adams et al., 2008) .
The synergistic interaction of A2AR with mGlu5R observed in the present study is consistent with evidence for the existence of heterodimeric A2AR-mGlu5R complexes within the striatum . The presence of a functional A2AR-mGlu5R interaction is further supported by the significant reduction of mGlu5R binding in the ventral striatum of A2AR KO mice compared to WT. While it is possible that this down-regulation of mGlu5R binding reflects compensatory neuroadaptations due to the deletion of A2AR, these observations may also have resulted from the inability of mGlu5R to interact with A2AR in the KO mice. These results are consistent with Unlike MAP, chronic cocaine administration did not alter mGlu5R binding. Additionally, A2AR
deletion did not affect mGlu5R binding in chronically cocaine-treated mice suggesting a lack of A2AR-mGlu5R in the locomotor-enhancing effects of cocaine. This is in agreement with the absence of any effect of combined administration of sub-threshold doses of A2AR and mGlu5R
antagonists on cocaine-induced ambulatory and stereotypic rearing activity observed in our study. Nonetheless, this does not necessarily preclude an involvement of this receptor interaction on other behavioral effects of cocaine. Indeed, although Brown et al, (2012) did not detect an A2AR-mGlu5R interaction in regulating the acute enhanced locomotor responses of cocaine, they provided evidence for the involvement of such an interaction in mediating the reinforcing effects of cocaine.
In order to further assess the role of A2AR-mGlu5R interaction in the reinforcing properties of MAP, we investigated the effects of co-administration of sub-threshold doses of A2AR-mGlu5R
antagonists in MAP-induced CPP. This is the first study, to our knowledge, to show complete Interestingly, genetic deletion of mGlu5R did not affect the development of MAP-induced CPP in mice (Chesworth et al., 2013) , whereas activation of A2AR reduced the development of MAPinduced CPP (Kavanagh et al., 2015) , suggesting a distinct function of A2AR-mGlu5R interaction vs A2AR and mGlu5R on their own on the development of MAP-induced CPP. Since combined administration of A2AR-mGlu5R antagonists was also able to prevent MAP-induced locomotor and stereotypic responses, it is hence plausible that these MAP-related behaviors are regulated by common neural circuits likely localized in the striatum, a brain area underlying Pavlovian conditioning responses (Robbins et al., 2008) . Specifically, the mesolimbic DAergic system, projecting from the ventral tegmental area to the Acb, has been implicated in both the locomotor and the reinforcing properties of psychostimulant drugs of abuse (Koob, 1992) . Similarly, psychostimulant-induced stereotypic behavior has been demonstrated to involve the DAergic system in the striatum and more specifically the DA D2R (Amalric and Koob, 1993; Berke and Hyman, 2000) . Interestingly, in our study, A2AR gene deletion did not affect striatal D2R binding either in treatment naïve mice, or in chronically MAP-or cocaine-treated mice suggesting a lack of involvement of A2AR-D2R interactions in the actions of psychostimulants, at least at the receptor binding level. Although there is evidence suggesting that post-synaptic A2AR-D2R
interactions can negatively modulate the behavioral effects of psychostimulants (Ferre et al., 1997; Filip et al., 2006; Poleszak and Malec, 2002) , it has been suggested that the actions of presynaptic A2AR receptors dominate over the postsynaptic A2AR receptors (Shen et al., 2008) , which may explain why A2AR receptors do not modulate D2R binding following chronic psychostimulant treatment. However, multiple allosteric interactions have been described for
A2AR-D2R heteromer, which can differentially modulate G protein-dependent and independent signalling (Navarro et al., 2014).
In summary, our findings support the existence of functional striatal interactions between A2AR
and mGlu5R in modulating MAP-but not cocaine-induced locomotor and stereotypic rearing responses. We also demonstrated a key role of this interaction in positively modulating MAPseeking behavior. These pre-clinical data highlight the potential of therapeutic agents which simultaneously target A2AR and mGlu5R for the treatment of MAP addiction. The fact that this combination of sub-threshold doses of A2AR and mGlu5R antagonists is neither sedating (Supplementary Figure S4) , nor rewarding or aversive ( Figure 3C ) and at the same time it effectively prevents the motor enhancing and reinforcing effects of MAP, makes its potential progress towards clinical development for the treatment of MAP addiction especially appealing. 
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